Drug Misuse and Hepatitis C Virus Infection Profiles for Three Generations of Patients Being Monitored for Prescription Drug Adherence
- PMID: 30334927
- PMCID: PMC6430589
- DOI: 10.1097/ADM.0000000000000460
Drug Misuse and Hepatitis C Virus Infection Profiles for Three Generations of Patients Being Monitored for Prescription Drug Adherence
Abstract
Objectives: Two epidemics in the United States are related: opioid drug injection and hepatitis C virus (HCV) infection. This study quantifies the relationship between illicit/prescription drug misuse and HCV infection in 3 population generations: baby boomers (born 1945-1965, inclusive), pre-baby boomers, and post-baby boomers.
Methods: This retrospective study included prescription drug consistency (March-December 2015) and HCV (2011-2015) patient test results performed at a large national clinical reference laboratory. HCV positivity, drug use consistency/inconsistency with prescribed drug information, type of inconsistent use, and inconsistent use of individual drug classes were assessed.
Results: This study evaluated 39,231 prescription drug monitoring and HCV sets of test results from 18,410 patients. Of these patients, 25.1% tested positive for HCV and 57.3% demonstrated drug test results that were inconsistent with the prescribed medication(s). The types of drug test inconsistency differed substantially between HCV-positive and -negative patients, particularly testing positive for both non-prescribed drugs and prescribed drugs. Specimens from HCV-positive baby boomer and post-baby boomers demonstrated non-prescribed use of opioids and many other drug classes more often than from HCV-negative patients.
Conclusions: The rates of inconsistent drug test results and types of drugs misused suggest that HCV-positive patients are more likely than HCV-negative patients to display high-risk behavior, even beyond opioid use. This difference is most pronounced in the post-baby boomer generation. Healthcare professionals should consider these patterns and how they differ by generation when monitoring for both prescription and illicit drugs, the results of which can impact treatment decisions including prescribing analgesics.
Conflict of interest statement
This work was funded by Quest Diagnostics. Quest Diagnostics provided support in the form of salaries for FLM, JKN, and HWK and consulting fees for JG, but did not have any additional role in the study design, collection, analysis, interpretation of data, writing of the manuscript, or decision to publish. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. None of the authors have any other conflict of interests to report.
Figures

Similar articles
-
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1. MMWR Surveill Summ. 2015. PMID: 26469747
-
Prescribing of Opioids and Benzodiazepines Among Patients With History of Overdose.J Addict Med. 2019 Sep/Oct;13(5):396-402. doi: 10.1097/ADM.0000000000000513. J Addict Med. 2019. PMID: 30844876 Free PMC article.
-
Concurrent Use of Opioids and Benzodiazepines: Evaluation of Prescription Drug Monitoring by a United States Laboratory.J Addict Med. 2017 Nov/Dec;11(6):420-426. doi: 10.1097/ADM.0000000000000354. J Addict Med. 2017. PMID: 28953504 Free PMC article.
-
Prescription drug overdoses: a review.J Safety Res. 2012 Sep;43(4):283-9. doi: 10.1016/j.jsr.2012.08.009. Epub 2012 Aug 25. J Safety Res. 2012. PMID: 23127678 Review.
-
An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada: is Europe next?Bone Joint J. 2017 Jul;99-B(7):856-864. doi: 10.1302/0301-620X.99B7.BJJ-2016-1350.R1. Bone Joint J. 2017. PMID: 28663389 Review.
References
-
- Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007; 18:352–358. - PubMed
-
- Belani H, Chorba T, Fletcher F, et al. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases and tuberculosis for persons who use drugs illicitly. Summary guidance from CDC and the U.S. Department of Health and Human Services. MMWR Recomm Rep 2012; 61 (No. RR-5):1–40. - PubMed
-
- Centers for Disease Control and Prevention (CDC). 2010. Sexually Transmitted Diseases Treatment Guidelines, 2010. Available at: http://www.cdc.gov/std/treatment/2010/hepC.htm Accessed July 18, 2017.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical